文献类型：期刊文章

作　　者：刘宝东[1] 叶欣[2] 范卫君[3] 李晓光[4] 冯威建[5] 卢强[6] 毛宇[7] 林征宇[8] 李鲁[9] 庄一平[10] 倪旭东[11] 沈加林[12] 傅毅立[13] 韩建军[14] 李忱瑞[15] 柳晨[16] 杨武威[17] 苏志勇[18] 吴志远[19] 刘磊[1]

Baodong LIU;Xin YE;Weijun FAN;Xiaoguang LI;Weijian FENGs;Qjang LU;Yu MAO;Zhengyu LIN;Lu LI;Yiping ZHUANG;Xudong Ni;Jialin SHEN;Yili FU;Jianjun HAN;Chenrui LI;Wuwei YANG;Zhiyong SU;Zhiyuan WU;Lei LIU(Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250100, China;Imaging and In- terventional Center, Sun Yat-sen University Cancer Center, Guangzhou 510060, China;Department of Tumor Mini- mally Invasive Therapy, Beijing Hospital, Beijing 100005, Chin;Department of Oncology, Fuxing Hospital, Capital Medical University, Beijing 100038, China;Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi＇an 710038, China;Department of Thoracic Surgery, Hohhot First Hospital, Inner Mongolia, Hohhot 010020, China;Department of Interventional Therapy, the First Affiliated Hospital of Fujian Medical Uni- versity, Fuzhou 350005, China;Department of Thoracic Surgery, 306th Hospital of PLA, Beijing 100101, China;Department of lnterventional Therapy, Jiangsu Cancer Hospital, Nanjing 210009, China;Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200001, China;Department of Tumor Interventional Therapy, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200001, China;Department of Thoracic Surgery, Chaoyang Hospital, Capital medical University, Beijing 100020, China;Department of Minimally Invasive Interventional Therapy, Shandong Provincial Tumor Hospital, ]inan 250117, China;Department of lnter- ventional Therapy, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100020, China;Department of Interventional Therapy, Beijing Cancer Hospital, Beijing 100142, China;Department of Tumor Minimally Invasive Therapy, 307th Hospital of PLA, Beijing 100071, China;Affiliated Hospital of Chifeng University, Chifeng 024005, China;Department of Interventional Radiology, Ruqin Hospital, Shanghai Jiaotong Universi

机构地区：[1]首都医科大学宣武医院胸外科,北京100053 [2]山东大学附属省立医院肿瘤科,济南250100 [3]中山大学肿瘤医院影像与微创介入中心,广州510060 [4]北京医院肿瘤微创中心,北京100005 [5]首都医科大学附属复兴医院肿瘤科,北京100038 [6]空军军医大学唐都医院胸外科,西安710038 [7]内蒙古自治区呼和浩特市第一医院胸外科,呼和浩特010020 [8]福建医科大学附属第一医院介入科,福州350005 [9]解放军306医院胸外科,北京100101 [10]江苏省肿瘤医院介入科,南京210009 [11]复旦大学附属中山医院胸外科,上海200001 [12]上海交通大学医学院附属仁济医院南院肿瘤介入科,上海200001 [13]首都医科大学附属北京朝阳医院胸外科,北京100020 [14]山东省肿瘤医院微创介入科,济南250117 [15]中国医学科学院肿瘤医院介入治疗科,北京100020 [16]北京大学肿瘤医院介入治疗科,北京100142 [17]解放军307医院肿瘤微创治疗科,北京100071 [18]赤峰学院附属医院胸外科,赤峰024005 [19]上海交通大学医学院附属瑞金医院放射介入科,上海200025

出　　处：《中国肺癌杂志》

年　　份：2018

卷　　号：21

期　　号：2

起止页码：76-88

语　　种：中文

收录情况：BDHX、BDHX2017、CAB、CAS、CSA、CSA-PROQEUST、CSCD、CSCD2017_2018、DOAJ、EMBASE、IC、JST、PROQUEST、PUBMED、RCCSE、SCOPUS、ZGKJHX、核心刊

摘　　要：1概述肺癌是最常见的恶性肿瘤之一,在世界各地,肺癌均居恶性肿瘤死亡构成比的第一位,其发病率和死亡率仍在不断升高。据世界卫生组织（World Health Organization,WHO）下属的国际癌症研究机构（International Agency for Research on Cancer,IARC）出版的GLOBOCAN 2012估计：全世界肺癌新发病例1 8 2.5万（男性124.2万,女性58.3万）.

关 键 词：射频消融治疗 肿瘤专家 影像引导 世界卫生组织  肺部 恶性肿瘤  死亡构成比 研究机构  

分 类 号：R734.2]